Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Ensysce Biosciences (ENSC) Interest Coverage Ratio (2020 - 2025)

Ensysce Biosciences (ENSC) has disclosed Interest Coverage Ratio for 6 consecutive years, with 587.39 as the latest value for Q3 2025.

  • On a quarterly basis, Interest Coverage Ratio fell 470.16% to 587.39 in Q3 2025 year-over-year; TTM through Sep 2025 was 457.19, a 11671.38% decrease, with the full-year FY2024 number at 5.22, up 82.78% from a year prior.
  • Interest Coverage Ratio was 587.39 for Q3 2025 at Ensysce Biosciences, down from 553.96 in the prior quarter.
  • In the past five years, Interest Coverage Ratio ranged from a high of 542.0 in Q2 2022 to a low of 1710.91 in Q1 2023.
  • A 5-year average of 310.87 and a median of 195.34 in 2024 define the central range for Interest Coverage Ratio.
  • Peak YoY movement for Interest Coverage Ratio: tumbled 36470.33% in 2021, then soared 119676.99% in 2022.
  • Ensysce Biosciences' Interest Coverage Ratio stood at 20.59 in 2021, then surged by 730.77% to 129.85 in 2022, then plummeted by 107.05% to 9.15 in 2023, then plummeted by 3534.11% to 332.6 in 2024, then tumbled by 76.6% to 587.39 in 2025.
  • Per Business Quant, the three most recent readings for ENSC's Interest Coverage Ratio are 587.39 (Q3 2025), 553.96 (Q2 2025), and 510.25 (Q1 2025).